HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Continuous ambulatory peritoneal dialysis for psoriasis. A report of four cases.

Abstract
Four patients with psoriasis were treated with continuous ambulatory peritoneal dialysis (CAPD). Two were being treated for renal failure; the other two had normal renal function and were being treated exclusively for psoriasis. With CAPD at a rate of three to four exchanges per day, the psoriasis cleared completely in the two patients with renal failure and improved in the other two. In the patients without renal failure, low-flow peritoneal dialysis (one exchange per day) seemed to be of some value in maintaining remission but was ineffective in treating more active disease. Long-term therapy (greater than or equal to 12 weeks) with three or four daily exchanges may be needed for initial complete remission, and continuous treatment may be needed to prevent relapse. Thus, CAPD shows promise for the study of psoriasis and may be a last-resort treatment for severe, disabling cases.
AuthorsZ J Twardowski, K D Lempert, B J Lankhorst, W A Welton, F C Whittier, P C Anderson, K D Nolph, R Khanna, B F Prowant, L M Schmidt
JournalArchives of internal medicine (Arch Intern Med) Vol. 146 Issue 6 Pg. 1177-9 (Jun 1986) ISSN: 0003-9926 [Print] United States
PMID3718105 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Chronic Disease
  • Evaluation Studies as Topic
  • Female
  • Glomerulonephritis (therapy)
  • Glomerulosclerosis, Focal Segmental (therapy)
  • Humans
  • Male
  • Middle Aged
  • Peritoneal Dialysis, Continuous Ambulatory (methods)
  • Psoriasis (complications, pathology, therapy)
  • Skin (pathology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: